NIXON PEABODY TRUST CO

Bank

Position in ABBV — AbbVie Inc.

CIK 1626757 BOSTON, MA

Position in ABBV

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,075,778

+$313,675 QoQ

Shares Held

8,249

+1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#1,932

of 4,153 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NIXON PEABODY TRUST CO holds $47,887,604 across 9 Drug Manufacturers - General names. ABBV ranks #5 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	16,298	$19,548,311
2	MRK	Merck & Co., Inc.	77,974	$10,019,659
3	AZN	Astrazeneca PLC	42,186	$7,999,309
4	JNJ	Johnson & Johnson	22,335	$5,672,419
5	ABBV	AbbVie Inc. This page	8,249	$2,075,778
6	GILD	Gilead Sciences, Inc.	11,564	$1,460,995
7	AMGN	Amgen Inc	1,381	$500,087
8	NVS	Novartis AG	2,136	$334,753

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,075,778	8,249	+1.8%	Shares	Sole	2026-07-27
2026-03-31	$1,762,103	8,102	-2.5%	Shares	Sole	2026-04-27
2025-12-31	$1,898,523	8,309	+18.4%	Shares	Sole	2026-02-06
2025-09-30	$1,625,179	7,019	+2.8%	Shares	Sole	2025-10-17
2025-06-30	$1,266,856	6,825	+0.0%	Shares	Sole	2025-08-08
2025-03-31	$1,429,554	6,823	+5.1%	Shares	Sole	2025-04-10
2024-12-31	$1,153,628	6,492	-4.8%	Shares	Sole	2025-02-05
2024-09-30	$1,347,208	6,822	0.0%	Shares	Sole	2024-11-07
2024-06-30	$1,170,109	6,822	0.0%	Shares	Sole	2024-07-26
2024-03-31	$1,242,286	6,822	-4.3%	Shares	Sole	2024-05-07
2023-12-31	$1,104,936	7,130	+282.7%	Shares	Sole	2024-02-09
2022-03-31	$302,010	1,863	-39.2%	Shares	Sole	2022-05-13
2021-12-31	$414,730	3,063	-34.4%	Shares	Sole	2022-02-08
2021-09-30	$503,752	4,670	—	Shares	Other	2021-11-04
No filing history on record for this holder in this stock.